Business
Tetra Bio-Pharma Announces Voting Results of 2021 Annual General and Special Meeting
Tetra Bio-Pharma Announces Voting Results of 2021 Annual General and Special Meeting.
About this update from Tetra Bio-pharma Inc.
[{"type":"text","content":"\n\n\n\nTetra Bio-Pharma Announces Voting Results of 2021 Annual General and Special Meeting\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTetra Bio-Pharma Announces Voting Results of 2021 Annual General and Special Meeting\nCanada NewsWire\nOTTAWA, ON, May 28, 2021\n\n\n\nOTTAWA, ON, May 28, 2021 /CNW/ - Tetra Bio-Pharma Inc. (\"Tetra\" or the \"Company\") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that all matters presented for approval at the Company's annual general and special meeting (the \"Meeting\") of shareholders of the Company held earlier today via live audio webcast online were approved.\nElection of Directors and Resolutions\nAll of the nominees listed in Tetra's management information circular dated April 20, 2021, as supplemented by a supplement to the management information circular dated May 18, 2021 (the \"Circular\"), namely Dr. Guy Chamberland, Dale Weil, Brent Norton, John Kim and Catherine Auld, were elected as directors of the Company until the next annual meeting of shareholders or until their successors are elected or appointed. The initial management information circular dated April 20, 2021 was listing Messrs. Guy Chamberland, Dale Norton and Carl Merton as well as Ms. Dale Weil as director nominees for the ensuing year. Following such date, management continued its efforts to identify suitable director candidates in order to increase its board membership, resulting in the nominations of John Kim and Catherine Auld as directors of the Corporation. In addition, on May 18, 2021, Mr. Carl Merton announced that he would not be seeking reelection as a director at this meeting of the shareholders.\nThe proposal to appoint McGovern Hurley LLP as auditor of the Company and to authorize the board of directors of the Company to fix the remuneration to be paid to the auditor, as presented in the Circular, was approved by a majority of shareholders at the Meeting.\nThe ordinary resolution of the shareholders of the Company approving the amended and res...